Amber Heijdra joined ImPhys as MSc student
Amber Heijdra is currently doing the master Biomedical Engineering at TU Delft. For her master thesis she will focus on predicting sarcomere mutations using radiomics at the Biomedical Imaging Group Rotterdam.
These mutations are in many cases the cause for developing hypertrophy cardiomyopathy, which is a heart disease that often manifests with a thickened left ventricle. However, the same mutation within a single family can result in remarkable variation in the degree of disease, the age of onset of symptoms, the clinical phenotype, and the final outcome. In addition, genetic testing is not available worldwide and is often not preferred by the patient. With the use of radiomics, a relationship can be established between image (MRI scan) and relevant clinical outcome (sarcomere mutation), in which quantitative features are combined with machine learning methods.
During this period she will be supervised by Frans Vos
